APOBEC3G genetic variants and their influence on the progression to AIDS.
about
AID and APOBECs span the gap between innate and adaptive immunityAntiretroelement activity of APOBEC3H was lost twice in recent human evolutionHIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsTurning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3)Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3HNatural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief OverviewMultiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allTarget cell APOBEC3C can induce limited G-to-A mutation in HIV-1Polymorphisms in the regulatory region of the Cyclophilin A gene influence the susceptibility for HIV-1 infectionIntrinsic cellular defenses against human immunodeficiency virusesEvidence for selection at HIV host susceptibility genes in a West Central African human populationAfrican genetic diversity: implications for human demographic history, modern human origins, and complex disease mappingPolymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals.Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS.T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity.Differences in APOBEC3G expression in CD4+ T helper lymphocyte subtypes modulate HIV-1 infectivity.Are viruses inhibited by APOBEC3 molecules from their host species?Host genetic determinants of human immunodeficiency virus infection and disease progression in children.Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo.HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptationGene expression variability within and between human populations and implications toward disease susceptibility.Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors.Host genetics influences on HIV type-1 disease.Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felidsIn vivo HIV-1 hypermutation and viral loads among antiretroviral-naive Brazilian patients.The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralizationGenetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infectionNFAT and IRF proteins regulate transcription of the anti-HIV gene, APOBEC3GCodon pairs of the HIV-1 vif gene correlate with CD4+ T cell countIntensity of deoxycytidine deamination of HIV-1 proviral DNA by the retroviral restriction factor APOBEC3G is mediated by the noncatalytic domain.A rare missense variant abrogates the signaling activity of tetherin/BST-2 without affecting its effect on virus releasePopulation level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation.Increased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys.Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression.APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso.Role of APOBEC3F Gene Variation in HIV-1 Disease Progression and Pneumocystis Pneumonia.Host factors influencing susceptibility to HIV infection and AIDS progression.
P2860
Q21131084-7DC6CA55-8E40-4FFE-955C-710EB71D970BQ24311460-785935F3-21D1-42FC-AAF0-70CD87FBBA5FQ24619114-929898FB-2DC8-459E-95EC-F4212E8B7BB5Q24645606-E72940EA-8105-485E-B970-FA46CB63827CQ24655418-28273788-CD67-4313-9FF5-0AA4A9A4CD1CQ26770401-74712786-423B-4A83-B93B-FD0CC193EEA4Q26823568-C49685FA-52EC-4FBA-8F85-7DC29E669942Q28469342-6BF13049-4F4F-4A94-8DF5-4FC6CD9958DFQ28474342-44D9B263-ACBF-4F93-A62E-F072A296606FQ28659575-E0D0C70B-0465-423D-8A57-E3EF26EFC1E6Q28710092-0E440723-9D34-4F79-A04C-0DD2E4B7E45EQ28748891-1CE641B0-08C4-4860-97AE-02B1C4F61BC4Q33270513-97BC842B-5004-45A8-9336-963CC0C7CDD7Q33288731-9C484228-8798-4FA3-B7A4-C0480623F58EQ33300132-E319262A-5082-40A6-B1AA-92AF8874A2D6Q33406252-FF86506A-6F12-41EF-BAA2-7C1AA6F2A2AAQ33434458-3AEC4AD2-7C7E-4195-9458-F10F6B7D13E5Q33575664-860129F8-AAA6-4FD2-B029-D5CFA5C1857CQ33594457-C3C5D6FA-2CF5-4331-99E0-5070E1C40133Q33615181-17B5EB35-8EC5-42D2-895C-CE36989A9D7FQ33650603-667FD337-F3F2-44BB-9DB7-9A725065D721Q33699581-0BDE8B1B-51F4-4E21-906A-FE9A91C080A3Q33701750-51E97F2F-74E2-46A6-AA61-EB5E1BE080D3Q33740120-94E189BB-7273-4925-A5F9-3A975F158161Q33775595-CDEAA256-A813-4723-BEFB-A1930B811C26Q33815187-613BB0E7-955A-45A0-B548-DE3E9857628BQ33966666-A982E7E2-5F10-4341-9F99-97598D97EE19Q34116867-F094D439-62BD-4815-964A-8188809579DBQ34234905-2153F125-7269-44DF-B746-E156D9912B47Q34434675-86F9AD0A-283B-4067-9CD4-DC25F9CC5C72Q34509329-8F3BFB10-3A13-4988-9132-234B3CA5FE95Q34665129-3FAF28C7-1B17-4047-90EA-CEF3A5CA3623Q34719668-9AA7DC1E-0194-480E-8FB0-88546F227657Q34929498-D30BF720-22AD-4572-A879-7B5B0EDC98A3Q35024235-5FFCAF71-D821-4F2D-8B39-46A9550F04E4Q35339284-424F3812-D3C0-4D11-A3D0-96C631732000Q35600919-7FDD30C4-A157-4AA9-96BC-3CEACBBFD88BQ35888106-96553FA3-A576-49A2-A4C5-97E7C1D0C83DQ35945852-F3291C03-7603-43BA-BE78-4C0EA5959669Q35995936-E97270A3-3C14-45F0-851F-60EF82B612A7
P2860
APOBEC3G genetic variants and their influence on the progression to AIDS.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
APOBEC3G genetic variants and their influence on the progression to AIDS.
@en
APOBEC3G genetic variants and their influence on the progression to AIDS.
@nl
type
label
APOBEC3G genetic variants and their influence on the progression to AIDS.
@en
APOBEC3G genetic variants and their influence on the progression to AIDS.
@nl
prefLabel
APOBEC3G genetic variants and their influence on the progression to AIDS.
@en
APOBEC3G genetic variants and their influence on the progression to AIDS.
@nl
P2093
P2860
P50
P1433
P1476
APOBEC3G genetic variants and their influence on the progression to AIDS
@en
P2093
Amalio Telenti
Cheryl A Winkler
Didier Trono
Gabriela Bleiber
George Nelson
Irene Alobwede
James J Goedert
John Phair
Priya Duggal
Sharyne Donfield
P2860
P304
11070-11076
P356
10.1128/JVI.78.20.11070-11076.2004
P407
P577
2004-10-01T00:00:00Z